New Zealand Markets open in 6 hrs 34 mins

Fresenius Medical Care AG & Co. KGaA (FME.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
72.46-0.22 (-0.30%)
At close: 5:35PM CEST
Full screen
Previous close72.68
Open72.56
Bid72.38 x 38700
Ask72.40 x 105300
Day's range72.12 - 72.72
52-week range53.50 - 81.10
Volume1,051,049
Avg. volume562,226
Market cap22.072B
Beta (5Y monthly)1.05
PE ratio (TTM)16.52
EPS (TTM)4.39
Earnings date29 Oct 2020
Forward dividend & yield1.20 (1.65%)
Ex-dividend date28 Aug 2020
1y target est80.61
  • Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day
    Business Wire

    Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

    Fresenius Medical Care, the world’s leading provider of dialysis products and services, today announced the launch of the organization’s first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific. On 17 September each year, the World Health Organization (WHO), international partners and all countries commemorate World Patient Safety Day: a day that aims to increase global awareness of the need to protect patients in healthcare settings. Fresenius Medical Care Asia Pacific has chosen this important day to highlight the crucial role that ultrapure dialysis fluid (UPDF) plays in reducing morbidity and mortality in hemodialysis (HD) patients,1 and to launch a multi-year initiative providing ongoing healthcare professional education to increase the uptake of high-quality dialysis fluid.

  • Here's Why You Should Invest in Fresenius Medical Stock Now
    Zacks

    Here's Why You Should Invest in Fresenius Medical Stock Now

    Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services.

  • Fresenius Medical (FMS) Q2 Earnings & Revenues Top Estimates
    Zacks

    Fresenius Medical (FMS) Q2 Earnings & Revenues Top Estimates

    Fresenius Medical's (FMS) second-quarter earnings benefit from strong segmental performance.